ArticleSurgical endoscopy2026
Impact of body mass index on outcomes after robotic transversus abdominis release in patients without obesity, with class I obesity, and with class II obesity: a multicenter study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is considered as a risk factor for postoperative complications after ventral hernia repair (VHR). While promising results of robotic VHR in patients with obesity have been demonstrated, outcomes stratified across BMI categories in patients undergoing robotic transversus abdominis release (rTAR) remain limited. In this multicenter study, we compared perioperative and long-term outcomes after rTAR in patients without obesity (BMI < 30 kg/m
methodsWe performed a retrospective cohort analysis of consecutive rTAR patients at five centers between February 2015 and July 2025. The primary outcome was overall complication rates; secondary outcomes included surgical site events (SSEs), including occurrences (SSOs), infections (SSIs), and hernia recurrences. Outcomes were analyzed using univariate tests. Multivariate logistic regression tests were run to identify independent risk factors.
resultsA total of 343 patients included in this study; 160 (46.6%) were patients without obesity, 117 (34.1%) patients had class I obesity, and 66 (19.2%) patients had class II obesity. Overall complication rates were comparable across groups (31.1% vs 27.6% vs 30.3%, p = 0.818). No significant differences observed in length of hospital stay, 30-day readmissions, Clavien-Dindo grades, Comprehensive Complication Index scores, or SSEs, including SSOs and SSIs. Hernia recurrence occurred in one patient per group. Multivariate analysis demonstrated that BMI category was not an independent predictor of complications. Independent risk factors for any postoperative complication included COPD (OR 3.45, 95% CI 1.58-7.11), prior wound infection (OR 2.22, 95% CI 1.19-4.11), non-use of the TEP approach (OR 1.94, 95% CI 1.10-3.43), bilateral TAR (OR 2.58, 95% CI 1.27-5.22), prolonged adhesiolysis > 30 min (OR 1.77, 95% CI 1.01-3.08), and lack of primary defect closure (OR 5.67, 95% CI 1.37-23.47). For SSEs specifically, COPD (OR 2.43, 95% CI 1.10-5.37), prior wound infection (OR 2.17, 95% CI 1.10-4.28), prolonged adhesiolysis (OR 1.96, 95% CI 1.09-3.52), and lack of primary defect closure (OR 4.78, 95% CI 1.36-16.78) were independent predictors.
conclusionComparable short- and long-term outcomes were observed with rTAR across patients without obesity, with class I obesity, and with class II obesity. Surgeons may need to consider comorbidities, particularly COPD and prior wound infection history, alongside operative factors such as TEP access, primary defect closure, and the careful application of bilateral TAR, in order to optimize patient outcomes.
Indexed as
Identifiers
42115371What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.